- Advertisement -

8 Contract Development and Manufacturing Companies to Watch

  AGC Biologics AGC Biologics has named Tadashi Murano, president of its AGC Life Science Company, as interim CEO while the company searches for a permanent...

New miniature heart could help speed heart disease cures

There’s no safe way to get a close-up view of the human heart as it goes about its work: you can’t just pop it...

CAR-T cells used to target glioblastoma

Immunotherapy is the new weapon against cancers and building upon existing research, a team of researchers from the Massachusetts General Hospital have devised a...

Plant Biotechnology Services Market in North America Size, Growth Scenarios, Trends...

A recent report by KD market insights titled as “Plant Biotechnology Services Market in North America Size, Trends & Opportunity Outlook – Forecast to 2025” provides the...

Sky’s the limit for biofuels

The United States has enough biomass potential to produce 35 billion gallons per year of aviation biofuel by 2050, a new report confirms. Credit: Credit:...

Neurodegenerative Treatments Build to a Tipping Point

Neurodegenerative diseases represent the greatest therapeutic challenge of our time. Worldwide, an estimated 60 million people suffer from neurodegenerative diseases, which impair the function...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

more new items

Recoded E. coli Promises More Scalable Weight Loss Drug Production

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain of Escherichia coli (E....

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...